JP2000506128A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000506128A5 JP2000506128A5 JP1997529954A JP52995497A JP2000506128A5 JP 2000506128 A5 JP2000506128 A5 JP 2000506128A5 JP 1997529954 A JP1997529954 A JP 1997529954A JP 52995497 A JP52995497 A JP 52995497A JP 2000506128 A5 JP2000506128 A5 JP 2000506128A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11722396A IL117223A0 (en) | 1996-02-22 | 1996-02-22 | Antipathogenic polypeptides and compositions comprising them |
| IL117223 | 1996-02-22 | ||
| PCT/IL1997/000066 WO1997031019A2 (en) | 1996-02-22 | 1997-02-20 | Antipathogenic peptides and compositions comprising them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000506128A JP2000506128A (ja) | 2000-05-23 |
| JP2000506128A5 true JP2000506128A5 (enExample) | 2004-11-11 |
Family
ID=11068576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9529954A Ceased JP2000506128A (ja) | 1996-02-22 | 1997-02-20 | 抗病原性ペプチドおよびこれらを含む組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6172038B1 (enExample) |
| EP (1) | EP0904291A2 (enExample) |
| JP (1) | JP2000506128A (enExample) |
| KR (2) | KR19990087100A (enExample) |
| CN (1) | CN1216549A (enExample) |
| AU (1) | AU730069B2 (enExample) |
| BR (1) | BR9707691A (enExample) |
| CA (1) | CA2247025A1 (enExample) |
| CZ (1) | CZ264398A3 (enExample) |
| EA (1) | EA199800754A1 (enExample) |
| IL (2) | IL117223A0 (enExample) |
| NZ (1) | NZ331219A (enExample) |
| WO (1) | WO1997031019A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9807456A (pt) * | 1997-02-20 | 2000-04-25 | Yeda Res & Dev | Peptìdios antipatogênicos sintéticos e composições que compreendem os mesmos |
| US6818213B1 (en) | 1998-07-13 | 2004-11-16 | Board Of Regents, The University Of Texas System | Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids |
| AU750414B2 (en) | 1998-07-13 | 2002-07-18 | Board Of Regents, The University Of Texas System | Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
| HK1042114B (zh) | 1998-10-23 | 2006-09-29 | Amgen K-A, Inc. | 与mp1受体结合并具有血小板生成活性的模拟二聚体血小板生成素肽 |
| GB0005703D0 (en) | 2000-03-09 | 2000-05-03 | Alpharma As | Compounds |
| IL139720A0 (en) * | 2000-11-16 | 2002-02-10 | Yeda Res & Dev | Diastereomeric peptides and pharmaceutical compositions comprising them |
| CA2529125A1 (en) * | 2003-06-19 | 2004-12-23 | Yeda Research & Development Co. Ltd. | Antimicrobial and anticancer lipopeptides |
| CA2572765C (en) | 2004-07-08 | 2013-05-21 | Amgen Inc. | Compound having improved bioefficiency when administered in a multidose regimen |
| US7442778B2 (en) | 2004-09-24 | 2008-10-28 | Amgen Inc. | Modified Fc molecules |
| WO2006068768A2 (en) * | 2004-11-24 | 2006-06-29 | Hanna Skubatch | Methods and compositions for treating conditions |
| WO2006128289A1 (en) * | 2005-06-02 | 2006-12-07 | University Of Manitoba | Use of brevinin-2r in the treatment of cancer |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| WO2007074457A2 (en) * | 2005-12-27 | 2007-07-05 | Yeda Research And Development Co. Ltd. | Histidine-containing diastereomeric peptides and uses thereof |
| CA2637221A1 (en) | 2006-02-10 | 2007-08-16 | Dermagen Ab | Novel antimicrobial peptides and use thereof |
| US9283260B2 (en) | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
| JP6205364B2 (ja) * | 2012-09-05 | 2017-09-27 | 株式会社メニコン | 薬物徐放性眼用レンズ及びその製造方法 |
| JP6093528B2 (ja) * | 2012-09-19 | 2017-03-08 | 株式会社ミルボン | スクリーニング方法 |
| US11103547B2 (en) | 2016-02-04 | 2021-08-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods for disrupting biofilms |
| GB2557654A (en) * | 2016-12-14 | 2018-06-27 | Uea Enterprises Ltd | Method for nucleic acid depletion |
| CN113528600A (zh) * | 2021-07-08 | 2021-10-22 | 石河子大学 | 一种利用沙门氏菌诱导蝇蛆制备抗菌肽的方法 |
| CN119607173A (zh) * | 2025-01-07 | 2025-03-14 | 天津医科大学朱宪彝纪念医院(天津医科大学代谢病医院、天津代谢病防治中心) | 小分子肽lklkll在制备降血糖产品中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258454A (en) * | 1988-09-01 | 1993-11-02 | Riso National Laboratory | Peptide synthesis method and solid support for use in the method |
-
1996
- 1996-02-22 IL IL11722396A patent/IL117223A0/xx unknown
-
1997
- 1997-02-20 WO PCT/IL1997/000066 patent/WO1997031019A2/en not_active Ceased
- 1997-02-20 EA EA199800754A patent/EA199800754A1/ru unknown
- 1997-02-20 CZ CZ982643A patent/CZ264398A3/cs unknown
- 1997-02-20 JP JP9529954A patent/JP2000506128A/ja not_active Ceased
- 1997-02-20 AU AU17319/97A patent/AU730069B2/en not_active Ceased
- 1997-02-20 US US09/125,605 patent/US6172038B1/en not_active Expired - Fee Related
- 1997-02-20 NZ NZ331219A patent/NZ331219A/xx unknown
- 1997-02-20 BR BR9707691A patent/BR9707691A/pt unknown
- 1997-02-20 CN CN97194000A patent/CN1216549A/zh active Pending
- 1997-02-20 EP EP97904561A patent/EP0904291A2/en not_active Ceased
- 1997-02-20 IL IL12573497A patent/IL125734A/xx not_active IP Right Cessation
- 1997-02-20 CA CA002247025A patent/CA2247025A1/en not_active Abandoned
- 1997-02-20 KR KR1019980706488A patent/KR19990087100A/ko not_active Withdrawn
-
1998
- 1998-02-19 KR KR1019997007477A patent/KR20000071187A/ko not_active Withdrawn